Literature DB >> 6461175

[Antimalarial activities of 25 derivatives of artemisinine against chloroquine-resistant plasmodium berghei (author's transl)].

H M Gu, B F Lu, Z X Qu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6461175

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN： 0253-9756


× No keyword cloud information.
  8 in total

1.  Stereoselective chlorothiolation of artemisinin-derived C-10 oxa terminal alkynes.

Authors:  Naresh Surineni; Pori Buragohain; Nabin C Barua
Journal:  Mol Divers       Date:  2015-06-19       Impact factor: 2.943

2.  Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria.

Authors:  S Looareesuwan; B Oosterhuis; B M Schilizzi; F A E Sollie; P Wilairatana; S Krudsood; Ch B Lugt; P A M Peeters; J O Peggins
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

Review 3.  Artemisia annua L.: a source of novel antimalarial drugs.

Authors:  H J Woerdenbag; C B Lugt; N Pras
Journal:  Pharm Weekbl Sci       Date:  1990-10-19

4.  Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation.

Authors:  Juan Wang; Liying Huang; Jian Li; Qiangwang Fan; Yicheng Long; Ying Li; Bing Zhou
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

5.  Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives.

Authors:  O Y Ke; E C Krug; J J Marr; R L Berens
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

Review 6.  Antimalarial drugs. An update.

Authors:  D C Warhurst
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

Review 7.  Qinghaosu (artemisinin): chemistry and pharmacology.

Authors:  Ying Li
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

Review 8.  Artemisinin anti-malarial drugs in China.

Authors:  Zongru Guo
Journal:  Acta Pharm Sin B       Date:  2016-02-18       Impact factor: 11.413
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.